The Valley Desk

NCT03066258 · Interventional trial

Safety and Tolerability of RGX-314 (Investigational Product) Gene Therapy for Neovascular AMD Trial

Overall registry status Completed

Phase 1 · Phase 2

Conditions Neovascular Age-related Macular Degeneration, Wet Age-related Macular Degeneration

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov